dermatomyositis的例句大全

Value of MRI in diagnosis of polymyositis and dermatomyositis

MRI诊断皮肌炎与多发性肌炎的探讨

The Study of Myositis Autoantibody and Muscle Magnetic Resonance Imaging in Polymyositis and Dermatomyositis

肌炎自身抗体谱和肌肉MRI对多发性肌炎及皮肌炎的诊断价值研究

Summarize dermatomyositis ( DM)/ polymyositis ( PM).

概述多发性肌炎（PM）、皮肤炎（DM）。

Objective To study Chinese medical pattern distribution of polymyositis ( PM) and dermatomyositis ( DM).

目的了解多发性肌炎（PM）和皮肌炎（DM）的中医证候分布特点。

Study on Association of Dermatomyositis with Four Types of Human Herpes Virus

皮肌炎与四种人类疱疹病毒相关性的研究

Methods The study group consisted of 22 patients proven by clinical features and laboratory examination, including 8 cases of dermatomyositis ( DM), 12 cases of polymyositis ( PM), and 2 cases of eosinophilic fasciitis.

方法经临床诊断的结缔组织病22例，其中皮肌炎（DM）8例、多肌炎（PM）12例和嗜酸性筋膜炎2例。

The Clinical Features of Dermatomyositis in Association with Interstitial Lung Disease

皮肌炎合并间质性肺疾病患者的临床特点

Interstitial pulmonary fibrosis in association with dermatomyositis: Report of 5 cases

皮肌炎并发间质性肺纤维化5例报告

The mutations of structure gene of MBL also closely correlate with the autoimmune diseases, such as SLE, RA, IgA nephritis and dermatomyositis.

MBL基因突变还与自身免疫病如（SLE、RA、IgA肾炎及皮肌炎等）密切相关。

Objective To investigate the polarization of Th1/ Th2/ Th3cell function of dermatomyositis/ polymyositis ( DM/ PM).

目的探讨皮肌炎（DM）/多发性肌炎（PM）的Th1/Th2/Th3细胞功能性极化。

Objective: To compare the therapeutic effectiveness of prednisone combined with other drugs with that of prednisone alone in the treatment of polymyositis ( PM) and dermatomyositis ( DM).

目的：比较泼尼松联合疗法和单用治疗多发性肌炎（PM）和皮肌炎（DM）的疗效。

Objective: To investigate the status of activation and apoptosis of peripheral blood mononuclear cells ( PBMC) in patients with polymyositis ( PM) and dermatomyositis ( DM).

目的：探讨多发性肌炎（PM）皮肌炎（DM）的外周血单一核细胞（PBMC）活化和凋亡的状态。

Methods Twenty nine SLE patients with AVN of bone, 40 SLE patients and 20 polymyositis ( PM)/ dermatomyositis ( DM) patients without AVN were selected randomly from the inpatient.

方法统计本院发生无菌性骨坏死住院的29例SLE病人，同时随机抽样不伴有无菌性骨坏死的40例SLE和20例皮肌炎／多发性肌炎（DM／PM）病人作为对照组。

Connective tissue disease ( CTD) includes many diseases. For instance, lupus erythematosus, scleroderma, rheumatoid arthritis, sjogren syndrome, dermatomyositis/ multiple myositis and vasculitis.

结缔组织病（CTD）包括许多种疾病，如红斑狼疮、硬皮病、类风湿关节炎、干燥综合征、皮肌炎/多发性肌炎及血管炎等。

The most prevalent subtypes are multiple polymyositis ( PM), dermatomyositis ( DM) and inclusion body myositis ( IBM). The adenosine is the signaling molecule of autocrine or paracrine pathway, and plays an important role in maintaining the internal environment stability.

以多发性肌炎（PM）、皮肌炎（DM）和包涵体肌炎（IBM）3个亚型最为多见。腺苷是细胞自分泌或旁分泌途径中的信号分子，在维持内环境稳定方面起重要作用。

Objective To determine the anti-Jo-1 antibody and its clinical features correlation in patients with polymyositis or dermatomyositis.

目的摇对69例多发性肌炎/皮肌炎（PM/MD）病人抗Jo-1抗体进行检测，了解抗Jo-1抗体阳性与PM/DM临床症状的相关性及对PM/DM的诊断价值。

The positive rate of anti Mi 2 antibodies was 26 1% ( 12/ 46) in dermatomyositis and 4 5% ( 2/ 44) in polymyositis respectively.

抗Mi2抗体在DM和多发性肌炎中的阳性率分别为261%（1246）和45%（244）。

The ENA polypeptide in sera of 52 patients with dermatomyositis ( DM)/ polymyositis ( PM) were measured by immunoblotting technique, the positive rate of Jo 1 antibody is 13.3% and 31.8% respectively.

应用免疫印迹技术测定52例皮肌炎和多发性肌炎病人血清可提取性核抗原（ENA）多肽抗体，其中Jo－1抗体的阳性率分别为13.3%和31.8%。

There was no cross reaction in the sera from 72 patients with dermatomyositis or polymyositis ( DM/ PM), from 48 patients with progressed systemic scleroderma ( PSS), and from 78 patients with mixed connective tissue disease ( MCTD).

对皮肌炎和多发性肌炎（DM/PM）72份、硬皮病（PSS）48份和混合性结缔组织病（MCTD）78份血清亦无交叉反应出现。

Generally, they can be classified into three different subgroups: polymyositis, dermatomyositis and inclusion body myositis.

一般来说，它们可分为三个不同的亚组：多发性肌炎，皮肌炎和包涵体肌炎。